PhaseBio Pharmaceuticals' Grant

PhaseBio Pharmaceuticals raised a round of funding on December 02, 2010. Investors include Qualifying Therapeutic Discovery Project.

PhaseBio Pharmaceuticals (PHAS) is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's …

Articles about PhaseBio Pharmaceuticals' Grant: